Gene Query: DENND2D

Dataset Description Geneva Score
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 68.33
BCL11B 66.96
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 66.87
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 63.31
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 62.56
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 48.3
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 40.66
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 39.15
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 33.19
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 32.65
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 32.36
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 32.36
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 32.22
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 31.6
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 23.37
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 21.69
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 20.99
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 20.99
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 20.77
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 20.77
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 20.64
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 20.43
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 19.98
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 19.91
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 19.72
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 19.38
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 18.32
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 18.18
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 18.18
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 17.74
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 17.07
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 17.07
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 16.98
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 16.39
Dynamic 3D chromosomal landscapes in acute leukemia 16.39
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 16.3
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 16.3
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 15.7
Unique features and clinical importance of acute alloreactive immune responses 14.67
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 14.63
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 14.49
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 13.96
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 13.96
Primate transcript and protein expression levels evolve under compensatory selection pressures 13.96
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 13.42
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 13.17
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 13.17
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 12.6
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 12.55
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 12.55
Primary human trophoblast from term placenta 12.1
Trans-differentiation of human adult peripheral blood T cells into neurons 11.87
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 11.77
Androgen Receptor-regulated genes in prostate cancer cells 11.65
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 11.65
Global analysis of alternative splicing regulated by RBM10 11.48
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 11.31
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 11.31
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 11.02
Widespread intronic polyadenylation diversifies immune cell transcriptomes 10.94
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 10.93
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 10.79
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 10.74
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 10.65
Efficient derivation of microglia-like cells from human pluripotent stem cells 10.51
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 10.36
Intron retention induced by microsatellite expansions as a disease biomarker. 10.23
Stem and effector CD8 T-cells from human cancers 10.16
Identification of global regulators of T-helper cell lineage specification 10.12
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 10.12
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 10.07
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 10.04
Integrating single-cell transcriptomic data across different conditions, technologies, and species 10.02
The evolution of N6-methyladenosine in primates 9.97
Anti-inflammatory effect of indoleacrylic acid (IA) 9.9
BACH2 in human plasma cell fate decision 9.9
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 9.82
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 9.79
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 9.67
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 9.61
CircRNAome diversity in human mature B-cells, T-cells and monocytes 9.6
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 9.39
Human Treg NaCl stimulation 9.33
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 9.17
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 9.06
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 9.02
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 8.96
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 8.84
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 8.82
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 8.71
A practical evaluation of alignment algorithms for RNA variant calling analysis 8.43
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 8.32
A novel target of EZH1/2 for treatment of mantle cell lymphoma 8.23
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 8.18
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 8.16
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 8.0
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 7.91
Gene expression signatures of innate lymphoid cells from human blood 7.78
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 7.54
RNA sequencing of T-ALL (COG study) 7.48
Analyses of T-ALL (COG study) 7.48
Gene expression profiling of leukemia cells following asparagine depletion 7.42
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 7.4
mRNA expression profile of Lymphocytes 7.33
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 7.3
Transcriptomic profiling of human peripheral blood-derived mast cells 7.29
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 7.29
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 7.21
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 7.2
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 7.2
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 7.13
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 7.11
RNAseq of T-ALL upon long non coding rna purturbation 6.94
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 6.93
Patient-derived luminal breast cancer xenografts with progestins 6.93
JAK dependent survival of ALK- ALCL 6.89
Characterization of human ILC2 subsets 6.81
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 6.81
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 6.8
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 6.8
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 6.76
Trascriptome of thyroid cancer-induced macrophages 6.75
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 6.73
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 6.6
RNA seq comparison between scrambled and shGRP78 cells 6.59
RNA-sequencing of formalin fixed human primary melanoma tissue 6.58
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 6.57
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 6.57
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 6.49
Genome wide expression change in LCC2 and MCF-7 cells 6.36
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 6.33
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 6.28
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 6.28
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 6.23
naive T cell heterogeneity after neonatal thymectomy 6.14
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 6.1
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 6.08
Intrahepatic MAIT cell gene expression revealed by RNA-seq 6.08
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 6.06
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 6.06
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.05
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.05
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 6.01
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 6.01
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 5.99
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 5.93
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 5.91
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 5.86
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 5.84
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 5.84
MHC Transcriptomic landscape at haplotype-specific resolution 5.84
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 5.83
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 5.83
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 5.72
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 5.69
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 5.65
Transcriptomic analysis of human tonsillar TFH subsets 5.65
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 5.65
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.63
Transcriptional profiling of LS1034 cells treated with tepoxalin 5.63
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 5.59
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 5.59
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.59
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.59
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.59
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 5.57
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 5.56
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 5.52
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 5.51
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 5.46
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 5.46
snRNAs as regulators of alternative splicing 5.42
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 5.4
Identification of renal resident macrophages across species [C1] 5.37
circRNA profile in hypopharyngeal cancer 5.36
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.36
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 5.35
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 5.34
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 5.2
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 5.2
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.16
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.16
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 5.08
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 5.08
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.04
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 5.0
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 4.99
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 4.99
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 4.98
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 4.97
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 4.97
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 4.95
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 4.95
single cell RNA-seq from GM12878 (ENCSR673UIY) 4.94
RNA-seq analysis of AML cells in response to ASLAN003 4.88
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 4.88
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.81
RNA-seq differential expression studies: more sequence, or more replication? 4.8
Landscape of H3K4me3 in human CD19 cells 4.78
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 4.76
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.75
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.75
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 4.74
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 4.7
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 4.68
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 4.63
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 4.59
T47D RNA-seq and ChrRNA-seq data 4.59
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 4.59
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 4.57
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 4.57
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 4.57
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 4.57
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 4.55
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 4.55
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.53
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.53
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 4.39
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 4.38
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 4.34
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.33
Defective structural RNA processing in relapsing-remitting multiple sclerosis 4.27
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 4.25
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 4.23
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 4.22
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 4.21
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 4.16
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 4.16
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 4.16
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 4.12
Transcriptional responses of human insulinoma cells to acute cytokine exposure 4.12
Leucegene: ALL sequencing 4.07
RNA Sequencing of three pairs of gastric cancer 4.07
mRNA expression profile of Lymphocytes by high-throuput sequencing 4.03
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 3.98
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.88
Identification of long noncoding RNAs regulated by p53 3.87
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.83
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 3.82
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 3.82
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 3.76
RNA-seq of stable and unstable section of human atherosclerotic plaques 3.72
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.72
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 3.72
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 3.67
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 3.67
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 3.66
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 3.66
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 3.64
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.56
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 3.56
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.54
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 3.53
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.51
Identification of long noncoding RNAs in T-ALL cell lines 3.5
Differential Gene Expression between MCF10A and MCF7 cells 3.5
Seletive inhibition of CDK9 in DLBCL cell lines 3.5
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 3.48
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 3.48
The conserved transcriptional landscapes in human spermatogenesis 3.45
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 3.4
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 3.39
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 3.38
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.36
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 3.35
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 3.35
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 3.3
Hepatosplenic T cell lymphoma 3.29
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 3.29
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.28
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.25
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.25
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 3.24
Discovering human diabetes-risk gene function with genetics and physiological assays 3.21
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 3.2
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.2
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 3.19
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 3.19
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 3.17
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.17
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 3.16
RNA-seq of resting and activated CD4+ T cells +-JQ1 3.14
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 3.11
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 3.11
Gene expression activation in CLL mediated by MSCs contact 3.1
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 3.1
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.98
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.97
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.88
Be1 and Be2 B cells are transcriptionally distinct 2.86
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 2.85
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 2.85
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 2.82
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.75
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.75
Developmental stage specific chromosome architecture in human erythroid cells 2.7
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 2.7
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 2.69
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 2.69
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 2.69
MAIT cell RNA sequencing 2.66
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 2.64
Landscape and variation of RNA secondary structure across the human transcriptome 2.63
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 2.62
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 2.62
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.59
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.53
RNA-Seq and expression data from human adipose tissue 2.53
Identification of renal resident macrophages across species 2.53
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 2.51
Transcriptomes in healthy and CHB fetal hearts 2.5
Clinker: visualizing fusion genes detected in RNA-seq data 2.48
Dysregulated immune system networks in war veterans with PTSD 2.48
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 2.47
Generation and functional characterization of MDSC-like cells 2.46
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 2.43
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 2.35
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.34
Energy Metabolism during Anchorage-Independence 2.33
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.33
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.33
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 2.32
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 2.32
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 2.32
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.3
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 2.29
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 2.29
RNA sequencing of matched nephrectomy samples [RNA-seq] 2.29
Polarized B -cell functions 2.27
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 2.27
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 2.26
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.25
An optimization system for isolating and sequencing of single human colon cancer cells 2.23
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 2.21
Human T-cell lymphoblastic lymphoma samples and control thymuses 2.21
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.19
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.19
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.18
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 2.16
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 2.15
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 2.13
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.12
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 2.1
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.1
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.09
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.08
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.07
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.07
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.04
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 2.04
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 2.04
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 2.04
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.02
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 2.0
Electronic cigarettes 1.99
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.99
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.95
The transcriptome of Kawasaki Disease arteritis 1.93
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.93
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.93
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 1.9
Transcriptional profile in human S. haematobium infection 1.9
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 1.86
Expression and functions of long noncoding RNAs during human T helper cell differentiation 1.85
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 1.85
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 1.84
Human Tfh cell RNA bulk sequencing 1.79
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 1.78
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.75
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 1.73
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 1.72
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.72
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 1.7
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 1.7
RNA-sequencing 1.66
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 1.61
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.61
Molecular analysis of renal cell carcinoma with unclassfied histology 1.61
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 1.6
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 1.59
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.58
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.56
Single cell transcriptome of peritoneal cells 1.56
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.56
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 1.55
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.52
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.51
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.5
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 1.46
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.45
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.41
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.41
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.39
Macrophage Ad5f35 PhenoMap 1.39
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.39
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 1.36
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 1.34
Measure transcript integrity using RNA-seq data 1.32
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 1.31
Expression patterns in chronic thromboembolic pulmonary hypertension 1.3
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 1.27
The DNA methylation landscape of human melanoma [RNA-Seq] 1.27
The DNA methylation landscape of human melanoma 1.27
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.27
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.26
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 1.2
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.19
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.17
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 1.15
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 1.15
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.12
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.12
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.12
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.12
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.09
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 1.08
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.08
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.07
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.06
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 1.04
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.04
Gene expression profile of human placenta from T. Cruzi infected mothers 1.04
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.03
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.01
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.01
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.98
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.95
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 0.95
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 0.89
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.87
RNA-seq analysis and shRNA screen of breast cancer 0.85
RNA-seq analysis of breast cancer 0.85
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.83
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 0.82
Effects of rFVIIIFc on human macrophages 0.79
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.77
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.73
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.72
Aging-associated patterns in the expression of human endogenous retroviruses 0.71
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.71
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 0.7
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.66
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.64
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.62
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.62
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 0.61
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.59
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.58
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.56
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.56
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.53
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.52
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.5
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 0.48
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.46
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.46
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.45
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 0.44
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.44
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.43
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.42
Human Treg IL-12 stimulation 0.41
quanTIseq: quantifying immune contexture of human tumors 0.4
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.38
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.38
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.35
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.35
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 0.35
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.33
The Genetic Landscape of Diamond-Blackfan Anemia 0.32
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.31
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.31
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.3
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.29
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.29
Total RNA-Seq data from leukemic patients with complex structural variants 0.28
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.27
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.24
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.24
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.22
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.21
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.21
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.2
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.19
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.18
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.14
The expression profiles of GBC liver metastasis 0.14
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 0.1
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.08
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.08
The role of m6A/m-RNA methylation in stress response regulation 0.07
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.07
NAPRT activation of macrophages 0.06
Deep RNA sequencing of the human placental transcriptome 0.06
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.06
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.05
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.05
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.04
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.02
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation